一小段医学方面的英文翻译成中文,非常感谢!

一小段医学方面的英文翻译成中文,非常感谢!
There were 3 primary efficacy variables evaluated in this trial:
patient self- assessment of magnitude of pain via a 100 mm visual analog scale
(VAS), patient self- assessment of pain relief via a categorical relief scale
(0-5), and investigator's sensory skin testing (allodynia). Quantitative
Thermal Sensory Testing (QST) was done on select patients at the discretion of
the investigators for investigational research purposes.
Safety was evaluated
via the following: monitoring of systemic lidocaine blood levels following 6
hours of patch-use, patient's self-reporting of symptoms via a 27-item
side-effects check list, and skin examinations of the area treated.
The Sponsor analyzed the trial data using a
two-way analysis of variance controlling for treatment and investigationalsite for
the following studyefficacy variables: VAS pain
reduction (Sessions 1 and 2), pain relief (Sessions 1, 2 and 3),VAS pain
reduction during home use (days 1 to 21), and allodynia testing (sessions 1 and
2). The Sponsor also looked at data from the 7-day washout period collected
from patients who opted to participate in the open-label continuous use
extension.